Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial

Author:

Sharma Abhinav1ORCID,Marques Pedro1ORCID,Neuen Brendon L.23ORCID,Fletcher Robert A.2ORCID,Slee April4ORCID,Rapattoni Wally5ORCID,Ang Fernando G.5ORCID,Arnott Clare2678ORCID,Levin Adeera9ORCID,Verma Subodh1011ORCID,Perkovic Vlado2612ORCID,Mahaffey Kenneth W.13ORCID

Affiliation:

1. McGill University Health Centre Montreal Quebec Canada

2. The George Institute for Global Health, UNSW Sydney Sydney Australia

3. Royal North Shore Hospital Sydney Australia

4. New Arch Consulting Seattle Washington USA

5. Janssen Inc. Toronto Ontario Canada

6. Faculty of Medicine UNSW Sydney Sydney Australia

7. Department of Cardiology Royal Prince Alfred Hospital Sydney Australia

8. Sydney Medical School University of Sydney Sydney Australia

9. St. Paul's Hospital, Division of Nephrology University of British Columbia Vancouver British Columbia Canada

10. Division of Cardiac Surgery, St Michael's Hospital University of Toronto Toronto Ontario Canada

11. Applied Health Research Centre Li Ka Shing Knowledge Institute of St Michael's Hospital Toronto Ontario Canada

12. The Royal North Shore Hospital Sydney Australia

13. Stanford Center for Clinical Research, Department of Medicine Stanford University School of Medicine Stanford California USA

Funder

Janssen Research and Development

McGill University Health Centre

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3